Connect
MJA
MJA

Cardiovascular diseases

Letters

In reply: Ventricular tachycardia following ingestion of a commonly used antihistamine

Dennis L Kuchar, Bruce D Walker and Charles W Thorburn

Med J Aust 2003; 178 (5): 246

Letters

Ventricular tachycardia following ingestion of a commonly used antihistamine

Philip T Sager and Enrico P Veltri

Med J Aust 2003; 178 (5): 245-246

Book reviews

Pragmatic approach to clinical audit

Ian A Scott

Med J Aust 2003; 178 (6):

Editorials

Cardiovascular risk factors: when should we treat?

Andrew M Tonkin, Stephen S Lim and Henrik Schirmer

Med J Aust 2003; 178 (3): 101-102

Research

Risk functions for prediction of cardiovascular disease in elderly Australians: the Dubbo Study

Leon A Simons, Judith Simons, Latha Palaniappan, Yechiel Friedlander and John McCallum

Med J Aust 2003; 178 (3): 113-116 Free

Letters

Fatal envenomation by jellyfish causing Irukandji syndrome

Paul M Bailey

Med J Aust 2003; 178 (3): 139-140

Letters

In reply: Guideline-discordant care in acute myocardial infarction: predictors and outcomes

Ian A Scott and Catherine M Harper

Med J Aust 2002; 177 (10): 574-574

Clinical update

Chlamydia pneumoniae and cardiovascular disease

Mikkel M Larsen, Birgitte Moern, Paul L Andersen, Lars J Ostergaard and Andrew Fuller

Med J Aust 2002; 177 (10): 558-562 Free

Letters

Guideline-discordant care in acute myocardial infarction: predictors and outcomes

Kristen J Pearson

Med J Aust 2002; 177 (10): 573-574

Conference report

Global cardiology comes to Australia: 14th World Congress of Cardiology, Sydney, 5–9 May 2002

Saul B Freedman

Med J Aust 2002; 177 (9): 473-475

Editorials

The Heart Protection Study: implications for clinical practice

Ian Hamilton-Craig

Med J Aust 2002; 177 (8): 407-408

Research

Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?

Paul P Glasziou, Simon D Eckermann, Sarah E Mulray, R John Simes, Andrew J Martin, Adrienne C Kirby, Susan Caleo, Jane P Hall, Harvey D White and Andrew M Tonkin

Med J Aust 2002; 177 (8): 428-434 Free

Medicine and the media

Media coverage of scientific presentations

Julie Robotham and Robert Whitehead

Med J Aust 2002; 177 (7): 375-375

Editorials

Aspirin for the primary prevention of cardiovascular events

Graeme J Hankey and John W Eikelboom

Med J Aust 2002; 177 (7): 343-344

Medicine and the media

Media coverage of scientific presentations

Terry D Bolin and James V Bertouch

Med J Aust 2002; 177 (7): 374-374

For debate

Clinical trials without consent: some experiments simply cannot be done

Michael C Kennedy

Med J Aust 2002; 177 (1): 40-42

Lessons from practice

Transient cortical blindness related to coronary angiography and graft study

Kiam K Lim and Dorothy J Radford

Med J Aust 2002; 177 (1): 43-44 Free

Book reviews

A handy guide to coronary care

Peter L Thompson

Med J Aust 2002; 177 (5):

Research

Guideline-discordant care in acute myocardial infarction: predictors and outcomes

Ian A Scott and Catherine M Harper

Med J Aust 2002; 177 (1): 26-31 Free

Editorials

Ambulatory blood pressure monitoring and "white coat" hypertension: saving costs

Barry P McGrath

Med J Aust 2002; 176 (12): 571-572

Research

Cost analysis of ambulatory blood pressure monitoring in initiating antihypertensive drug treatment in Australian general practice

Ben Ewald and Brita Pekarsky

Med J Aust 2002; 176 (12): 580-583 Free

Position statement

Ambulatory blood pressure monitoring

Barry P McGrath, and on behalf of the National Blood Pressure Advisory Committee of the National Heart Foundation of Australia

Med J Aust 2002; 176 (12): 588-592 Free

Letters

An ecological perspective of cholesterol

Christopher H Cantor

Med J Aust 2002; 176 (11): 564

Notable cases

Extracorporeal membrane oxygenation in fulminant myocarditis complicating systemic lupus erythematosus

Michael C H Leung, Richard W Harper and John Boxall

Med J Aust 2002; 176 (8): 374-375 Free

Letters

Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes

Roger E Peverill

Med J Aust 2002; 176 (6): 296-297